| Product Code: ETC9923255 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Arab Emirates (UAE) Fragment Based Drug Discovery Market Overview |
3.1 United Arab Emirates (UAE) Country Macro Economic Indicators |
3.2 United Arab Emirates (UAE) Fragment Based Drug Discovery Market Revenues & Volume, 2021 & 2031F |
3.3 United Arab Emirates (UAE) Fragment Based Drug Discovery Market - Industry Life Cycle |
3.4 United Arab Emirates (UAE) Fragment Based Drug Discovery Market - Porter's Five Forces |
3.5 United Arab Emirates (UAE) Fragment Based Drug Discovery Market Revenues & Volume Share, By Component, 2021 & 2031F |
3.6 United Arab Emirates (UAE) Fragment Based Drug Discovery Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 United Arab Emirates (UAE) Fragment Based Drug Discovery Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 United Arab Emirates (UAE) Fragment Based Drug Discovery Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investment in research and development in the UAE pharmaceutical industry |
4.2.2 Growing prevalence of chronic diseases driving the demand for innovative drug discovery techniques |
4.2.3 Government initiatives to support and promote the healthcare and pharmaceutical sectors in the UAE |
4.3 Market Restraints |
4.3.1 High costs associated with fragment-based drug discovery research and development |
4.3.2 Limited availability of skilled professionals in the field of fragment-based drug discovery in the UAE |
4.3.3 Stringent regulatory requirements for drug approval and commercialization in the UAE |
5 United Arab Emirates (UAE) Fragment Based Drug Discovery Market Trends |
6 United Arab Emirates (UAE) Fragment Based Drug Discovery Market, By Types |
6.1 United Arab Emirates (UAE) Fragment Based Drug Discovery Market, By Component |
6.1.1 Overview and Analysis |
6.1.2 United Arab Emirates (UAE) Fragment Based Drug Discovery Market Revenues & Volume, By Component, 2021- 2031F |
6.1.3 United Arab Emirates (UAE) Fragment Based Drug Discovery Market Revenues & Volume, By Fragment Screening, 2021- 2031F |
6.1.4 United Arab Emirates (UAE) Fragment Based Drug Discovery Market Revenues & Volume, By Biophysical Techniques, 2021- 2031F |
6.1.5 United Arab Emirates (UAE) Fragment Based Drug Discovery Market Revenues & Volume, By NMR Spectroscopy, 2021- 2031F |
6.1.6 United Arab Emirates (UAE) Fragment Based Drug Discovery Market Revenues & Volume, By Differential Scanning Fluorimetry (DSF) Assay, 2021- 2031F |
6.1.7 United Arab Emirates (UAE) Fragment Based Drug Discovery Market Revenues & Volume, By Fluorescence Polarization, 2021- 2031F |
6.1.8 United Arab Emirates (UAE) Fragment Based Drug Discovery Market Revenues & Volume, By Isothermal Titration Calorimetry, 2021- 2031F |
6.1.9 United Arab Emirates (UAE) Fragment Based Drug Discovery Market Revenues & Volume, By Surface Plasmon Resonance (SPR), 2021- 2031F |
6.1.10 United Arab Emirates (UAE) Fragment Based Drug Discovery Market Revenues & Volume, By Surface Plasmon Resonance (SPR), 2021- 2031F |
6.2 United Arab Emirates (UAE) Fragment Based Drug Discovery Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 United Arab Emirates (UAE) Fragment Based Drug Discovery Market Revenues & Volume, By Oncology, 2021- 2031F |
6.2.3 United Arab Emirates (UAE) Fragment Based Drug Discovery Market Revenues & Volume, By Central Nervous System (CNS) Disorders, 2021- 2031F |
6.2.4 United Arab Emirates (UAE) Fragment Based Drug Discovery Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.2.5 United Arab Emirates (UAE) Fragment Based Drug Discovery Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F |
6.2.6 United Arab Emirates (UAE) Fragment Based Drug Discovery Market Revenues & Volume, By Metabolic Disorders, 2021- 2031F |
6.2.7 United Arab Emirates (UAE) Fragment Based Drug Discovery Market Revenues & Volume, By Inflammation & Autoimmune Diseases, 2021- 2031F |
6.3 United Arab Emirates (UAE) Fragment Based Drug Discovery Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 United Arab Emirates (UAE) Fragment Based Drug Discovery Market Revenues & Volume, By Academic & Research Institutions, 2021- 2031F |
6.3.3 United Arab Emirates (UAE) Fragment Based Drug Discovery Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.3.4 United Arab Emirates (UAE) Fragment Based Drug Discovery Market Revenues & Volume, By Contract Research Organizations (CROs), 2021- 2031F |
7 United Arab Emirates (UAE) Fragment Based Drug Discovery Market Import-Export Trade Statistics |
7.1 United Arab Emirates (UAE) Fragment Based Drug Discovery Market Export to Major Countries |
7.2 United Arab Emirates (UAE) Fragment Based Drug Discovery Market Imports from Major Countries |
8 United Arab Emirates (UAE) Fragment Based Drug Discovery Market Key Performance Indicators |
8.1 Number of research collaborations between local universities/institutes and pharmaceutical companies |
8.2 Percentage increase in the number of patents filed for fragment-based drug discovery technologies in the UAE |
8.3 Rate of adoption of fragment-based drug discovery techniques by local pharmaceutical companies |
9 United Arab Emirates (UAE) Fragment Based Drug Discovery Market - Opportunity Assessment |
9.1 United Arab Emirates (UAE) Fragment Based Drug Discovery Market Opportunity Assessment, By Component, 2021 & 2031F |
9.2 United Arab Emirates (UAE) Fragment Based Drug Discovery Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 United Arab Emirates (UAE) Fragment Based Drug Discovery Market Opportunity Assessment, By End User, 2021 & 2031F |
10 United Arab Emirates (UAE) Fragment Based Drug Discovery Market - Competitive Landscape |
10.1 United Arab Emirates (UAE) Fragment Based Drug Discovery Market Revenue Share, By Companies, 2024 |
10.2 United Arab Emirates (UAE) Fragment Based Drug Discovery Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here